 
 |
Becker Pharmaceuticals enables pharmaceutical, medical device, and biotechnology companies to rise above the competitive and complex challenges they face. An example of an engagement we performed for a Fortune 500 pharmaceutical manufacturer is highlighted in a recent Solution Source (PDF) success study. TMG helped this client integrate information and develop a strategy much more effectively and efficiently than ever before.
Look for the following strat i reports from Becker Pharmaceuticals in 2000:
- Biotechnology: The State of the Art Business and Science (January 2000) - This newly updated book provides an analytical summary of all technologies within the biotech industry. Although the largest and most successful bio-pharma firms have achieved success by developing and commercializing recombinant proteins, TMG has identified other key technologies that will lead the next wave of successes.
- Women's Health Outlook (January 2000) - This report delves into emerging trends, worldwide market projections, competitive analysis, and new technologies that impact the care and treatment of women. This publication answers questions pertaining to osteoporosis, cancer, contraception, menopause, urinary incontinence, fibroids, endometriosis, and more.
- Autoimmunity, Transplantation, and Inflammation Outlook (June 2000) - The focus of this report will be on trends and opportunities for treatment of the following autoimmune conditions: rheumatoid arthritis, multiple sclerosis, muscular dystrophy, and diabetes. In the transplant sections of the report, current therapeutic approaches and new therapies in development for bone marrow and solid organ transplants will be covered, as well as the common causes of mortality and morbidity in this patient population. Osteoarthritis is among the diseases that will be analyzed in the inflammatory section.
If you would like to learn more about any of these publications, or provide valuable insight into what data and analyses should be covered in future reports, please fill out our Contact Form.
|
|
